hp 873 has been researched along with Arrhythmias, Cardiac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, JG; Bowden, CL; Martinez, M; Prihoda, TJ; Singh, V | 1 |
| Drolet, B; Patoine, D; Pilote, S; Simard, C; Vigneault, P | 1 |
1 trial(s) available for hp 873 and Arrhythmias, Cardiac
| Article | Year |
|---|---|
An Open Trial of Iloperidone for Mixed Episodes in Bipolar Disorder.
Topics: Adult; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorder; Female; Humans; Isoxazoles; Male; Piperidines; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Urge; Young Adult | 2017 |
1 other study(ies) available for hp 873 and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
Topics: Action Potentials; Animals; Antipsychotic Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Heart Conduction System; HEK293 Cells; Humans; Isoxazoles; Male; Patch-Clamp Techniques; Perfusion; Piperidines; Potassium Channel Blockers; Risk Assessment; Telemetry; Time Factors; Transfection | 2012 |